Skip to main content

Advertisement

Log in

External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the risk of bladder cancer (BCa) in patients treated with brachytherapy for prostate cancer (PCa).

Methods

We retrospectively analyzed 583 patients with PCa who underwent brachytherapy with or without external beam radiotherapy (EBRT). We analyzed the disease-free survival (DFS) of BCa in patients with PCa who underwent brachytherapy with or without EBRT. We performed multivariate Cox regression analyses of DFS using age, EBRT, and Brinkman index (BI) score (number of cigarettes smoked per day × number of years smoking) ≥ 200 as variables for BCa after brachytherapy.

Results

Fourteen patients (2.4%) developed BCa after brachytherapy with or without EBRT. The percentage of high-grade urothelial carcinoma (UC) was 63.6%. A total of 85.7% of patients had non-muscle invasive BCa, and 14.3% of patients had muscle invasive BCa. DFS was longer in brachytherapy monotherapy than in combination therapy (brachytherapy + EBRT). Multivariate Cox regression analysis showed that a BI score ≥ 200 (Hazard Ratio (HR 8.61; 95% Confidence Interval (CI) 1.12–65.98) and EBRT combination (HR 3.29; 95% CI 1.03–10.52) were significantly associated with BCa development in patients with PCa treated with brachytherapy. Furthermore, patients with BI score ≥ 200 and EBRT combination had a significantly higher risk of BCa compared with patients with BI score < 200 (HR Log-rank test P = 0.010).

Conclusion

Most cases of BCa after brachytherapy with or without EBRT are high grade and invasive. We hypothesized that the EBRT combination might be a risk factor for BCa in patients with PCa who underwent brachytherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The datasets analyzed during the current study are available from the corresponding author upon reasonable request.

References

  1. Cooperberg MR, Broering JM, Litwin MS et al (2004) The contemporary management of prostate cancer in the United States: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CapSURE), a national disease registry. J Urol 171(4):1393–1401

    Article  PubMed  Google Scholar 

  2. Best T, Li D, Skol AD et al (2011) Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin’s lymphoma. Nat Med 17(8):941–943

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Boorjian S, Cowan JE, Konety BR et al (2007) Bladder cancer incidence and risk factors in men with prostate cancer: results from cancer of the prostate strategic urologic research endeavor. J Urol 177(3):883–887 (Discussion 887)

    Article  PubMed  Google Scholar 

  4. Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD (2006) Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66(3):669–673

    Article  PubMed  Google Scholar 

  5. Yoshida T, Kates M, Fujita K, Bivalacqua TJ, McConkey DJ (2019) Predictive biomarkers for drug response in bladder cancer. Int J Urol 26(11):1044–1053

    Article  PubMed  Google Scholar 

  6. Sandhu JS, Vickers AJ, Bochner B, MacheleDonat S, Herr HW, Dalbagni G (2006) Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer. BJU Int 98(1):59–62

    Article  PubMed  Google Scholar 

  7. Yee DS, Shariat SF, Lowrance WT et al (2010) Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. J Urol 183(5):1751–1756

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

TM: project development, data collection, data analysis, manuscript writing. KF: data analysis, manuscript writing. MH: data collection. MN: data collection. SA: data collection. EB: data analysis. MN: project development, data collection. KN: data collection. KY: project development, data collection. MI: data collection. MY: data collection. KN: project development, data collection. HU: project development, data collection.

Corresponding author

Correspondence to Takafumi Minami.

Ethics declarations

Conflict of interest

All authors declare no conflicts of interest.

Research involving human participants and/or animals

The study protocol was approved by the Institutional Ethics Review Board of Kindai University (approval no. R02-155).

Informed consent

Written informed consent was waived owing to the retrospective design.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Minami, T., Fujita, K., Hashimoto, M. et al. External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy. World J Urol 41, 1317–1321 (2023). https://doi.org/10.1007/s00345-023-04380-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-023-04380-5

Keywords

Navigation